RGRX Stock - RegeneRx Biopharmaceuticals, Inc.
Unlock GoAI Insights for RGRX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $76,761 | $76,761 | $76,761 | $76,762 | $69,667 |
| Gross Profit | $76,761 | $70,123 | $71,840 | $76,696 | $69,585 |
| Gross Margin | 100.0% | 91.4% | 93.6% | 99.9% | 99.9% |
| Operating Income | $-1,402,000 | $-1,329,000 | $-1,295,000 | $-1,262,000 | $-1,323,000 |
| Net Income | $-1,727,000 | $-1,598,000 | $-1,523,000 | $-1,404,000 | $-1,994,000 |
| Net Margin | -2249.8% | -2081.8% | -1984.1% | -1829.0% | -2862.2% |
| EPS | $-1.00 | $-0.01 | $-0.01 | $-0.01 | $-0.02 |
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue. It has strategic partnerships with Lee's Pharmaceutical Group and GtreeBNT Co., Ltd. The company was formerly known as Alpha 1 Biomedicals, Inc. and changed its name to RegeneRx Biopharmaceuticals, Inc. in 2000. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland.
Visit WebsiteEarnings History & Surprises
RGRXEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2023 | Mar 31, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.00 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.00 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.00 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.00 | — | — |
Q4 2021 | Nov 15, 2021 | — | $-0.00 | — | — |
Q3 2021 | Aug 6, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.00 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.00 | — | — |
Q4 2020 | Nov 13, 2020 | — | $-0.00 | — | — |
Q3 2020 | Aug 14, 2020 | — | $-0.00 | — | — |
Q2 2020 | May 15, 2020 | — | $-0.00 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.00 | — | — |
Q4 2019 | Nov 14, 2019 | — | $-0.00 | — | — |
Q3 2019 | Aug 14, 2019 | — | $-0.00 | — | — |
Q2 2019 | May 15, 2019 | — | $-0.00 | — | — |
Q1 2019 | Mar 29, 2019 | — | $-0.00 | — | — |
Q4 2018 | Nov 14, 2018 | — | $-0.00 | — | — |
Q3 2018 | Aug 9, 2018 | — | $-0.00 | — | — |
Latest News
Frequently Asked Questions about RGRX
What is RGRX's current stock price?
What is the analyst price target for RGRX?
What sector is RegeneRx Biopharmaceuticals, Inc. in?
What is RGRX's market cap?
Does RGRX pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to RGRX for comparison